PBI
46
3
BRK.B
40
2
ITW
55
2
HCA
44
5
EMR
51
3
URBN
46
-4
STI
7
-3
CNX
52
6
JPM
69
3
ABBV
53
-6
C
57
4
NKE
17
2
SLG
73
2
MA
55
2
PYPL
37
4
BXP
55
9
AKAM
53
5
BAC
62
5
KMI
46
-2
MUR
44
4
PBI
46
3
BRK.B
40
2
ITW
55
2
HCA
44
5
EMR
51
3
URBN
46
-4
STI
7
-3
CNX
52
6
JPM
69
3
ABBV
53
-6
C
57
4
NKE
17
2
SLG
73
2
MA
55
2
PYPL
37
4
BXP
55
9
AKAM
53
5
BAC
62
5
KMI
46
-2
MUR
44
4
Financhill
Back

Cyclacel Pharmaceuticals Vs. Nike Industry Stock Comparison

Sell
12

CYCC
Cyclacel Pharmaceuticals

Last Price:
1.57
Seasonality Move:
-15.51%
Sell
17

NKE
Nike

Last Price:
75.34
Seasonality Move:
6.25%
Sell
12
Cyclacel Pharmaceuticals (CYCC) is a Sell

Is Cyclacel Pharmaceuticals a Buy, Sell or Hold?

  • The current Cyclacel Pharmaceuticals [CYCC] share price is $1.66. The Score for CYCC is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • CYCC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
17
Nike (NKE) is a Sell

Is Nike a Buy, Sell or Hold?

  • The current Nike [NKE] share price is $76.04. The Score for NKE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • NKE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CYCC Stock Price Chart

What is Cyclacel Pharmaceuticals's stock price today?

  • The Cyclacel Pharmaceuticals share price today is $1.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYCC is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKE Stock Price Chart

What is Nike's stock price today?

  • The Nike share price today is $76.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKE is experiencing slight selling pressure.

CYCC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 44.71 Sell
Chaikin Money Flow: 10061 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.6 - 2.1) Sell
Bollinger Bands (100): (1.79 - 2.55) Sell

NKE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.2 Sell
Relative Strength Index (14 RSI): 21.68 Sell
Chaikin Money Flow: -4026097 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.28 - 98.68) Sell
Bollinger Bands (100): (89.69 - 101.25) Sell

CYCC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.69 Sell
20-day SMA: 1.77 Sell
50-day SMA: 2 Sell
200-day SMA: 3.55 Sell
8-day EMA: 1.68 Sell
20-day EMA: 1.77 Sell
50-day EMA: 1.96 Sell
200-day EMA: 3.95 Sell

NKE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 88.2 Sell
20-day SMA: 92.27 Sell
50-day SMA: 92.61 Sell
200-day SMA: 100.01 Sell
8-day EMA: 85 Sell
20-day EMA: 89.87 Sell
50-day EMA: 92.49 Sell
200-day EMA: 99.26 Sell

Cyclacel Pharmaceuticals Earnings Growth & CYCC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $4.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.23 per share, and an increase next year of $0.61 per share.

Nike Earnings Growth & NKE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.48 per share, and a decrease next year of $0.52 per share.

Cyclacel Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nike Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):